Similar results were obtained for the clinically tested metalloprotease inhibitor DPC‐333, which inhibited infection of A549‐ACE2 cells with the Innsbruck 1.2 isolate virus and the beta and delta virus variant to a similar extent as BB94 (Fig 2B). This evidence concerns the gene ACE2 and infection.